Will the Atlanta Falcons beat the Baltimore Ravens at home on October 12, 2026?
4 seats worked this question alone; the panel agreed within a few points, so no debate was run. Code ran every test and computed the number. How the desk works
Judged by Kalshi KXNFLGAME-26OCT11BALATL-ATL settlement at 2026-10-12: Kalshi KXNFLGAME-26OCT11BALATL-ATL: resolves YES if Atlanta Falcons win
The dispute that matteredCausal Skeptic (D, P=0.34) vs. the other three (P=0.37-0.39): D argues that the market-implied probability, while the only information-rich input, is a price reflecting unknown private information (injuries) rather than a validated causal signal, and that every other statistical test in the pool (regime splits, OLS on home-field, conditional win-rate comparisons) failed to reject the null — implying the committee has very little independent, mechanism-level evidence and should not over-trust the price's precision. A/B/C treat the converged 0.385 market print as close to the best available point estimate because it already impounds the late injury/news shock (d7/d8 spike) that no fundamental series captures. Resolution: I side with treating the market price as the dominant anchor (it is the freshest, most information-dense input and the injury-timing story is coherent) but shade the consensus below the raw 0.385 print toward 0.36, both because d2/d4/d5/d8 are not four independent confirmations (they are 1-2 underlying quote series resampled, per Analyst C's autocorrelation finding) and because D is correct that none of the fundamental causal claims survive scrutiny, so there is no second independent line of evidence to push probability back up toward the 0.55-0.57 generic home-field base rate.
Synthesis
- Market-implied ATL win probability has drifted from a season median of ~0.635 down to a repeated terminal value of 0.385 as of 2026-10-11 (game eve), across at least two sampled series (d2, d4).
- BAL's 7-game point-differential series: mean +12.14, most recent values 18, -7, 3, 6.
- BAL win rate over last 7 games: mean 0.857 vs ATL's 0.571 (d3/d4).
- An injury/news-count proxy series jumped sharply (0-1 to 2, and 1 to 5) in the final 2-3 days before the game, coincident with the drop in market-implied ATL probability.
- Lag-1 autocorrelation of 0.997 and cross-series correlation of 0.97 between d2 and d4, indicating these are largely the same slow-moving quote, not independent confirmations.
- Generic NFL home-team win base rate cited by two analysts as ~0.55-0.57 (not re-derived here from a fresh backtest).
- Calibration-weighted log-odds pooling of the four analysts' post-debate probabilities, producing the deterministic committee number of 0.37.
- Bootstrap confidence interval on BAL's point-differential series (s7).
- Autocorrelation/cross-correlation diagnostics on d2 vs d4 (s5) used to detect duplicated evidence.
- The late injury/news spike (d7/d8) is the proximate cause of the market's repricing of ATL downward from ~0.635 to ~0.385 (plausible causal story, not directly verified against a named player/event in this evidence set).
- The market price is closer to 'informationally efficient' than any fundamental series examined, because every tested causal/statistical signal (home-field OLS, regime splits, conditional win-rate tests) failed to reject the null at p<0.05.
- BAL's positive point-differential (bootstrap CI [3.02, 12.17], excludes zero) supports BAL being the genuinely stronger team by scoring margin this season, independent of the market price.
- P(ATL beats BAL at home on 2026-10-12) ≈ 0.36, 90%-ish CI [0.29, 0.43], essentially flat from the panel's pre-debate priors (unanimous within 0.05) and modestly below the raw market print of 0.385.
- Expected value of the ATL-win indicator variable over the 1-day horizon ≈ 0.36.
- Whether the generic ~0.55-0.57 home-field base rate has any residual relevance here, or whether it is fully superseded by the market price — the panel's causal tests cannot distinguish confounding/non-stationarity from a real but small home-field effect (s4 regime sign-flip).
- The specific nature/validity of the injury or news event implied by the d7/d8 spike — not independently confirmed by a named injury report in the evidence provided.
- Whether d5's 'market-implied probability' and d2/d4's series are drawn from the same underlying betting market or different proxies, which affects how much independent weight they deserve.
- Model uncertainty: all four analysts' calibration in this exact segment is weak-to-moderate (accuracy 28.6%-36%, brier 0.28-0.305 vs. a naive 0.25 for a 50/50 coin at these base rates), so the stated confidence intervals likely understate true uncertainty.
| Quantitative Researcher | 0.30 | Best combination of rigor and relevance: explicit bootstrap CI on BAL margin excluding zero, identifies the injury/news shock timing (d7/d8) that explains the price move, decent calibration (brier 0.284, n=25). Treated as primary anchor for the market-based estimate. |
| Market Positioning Analyst | 0.27 | High relevance and the only analyst who explicitly diagnosed that d2/d4 are near-duplicate samples of the same slow-moving quote (corr 0.97, lag-1 autocorr 0.997) rather than independent confirmation — credited for correctly deflating the weight of 'two series agreeing.' Calibration accuracy modest (32%). |
| Sports Analyst | 0.20 | Highest raw domain relevance to sports (1.0) and supplies the only team-level fundamental context (recent margin/win-rate trends), but worst calibration in-segment (accuracy 28.6%, brier 0.305), so down-weighted relative to stated relevance. |
| Causal Skeptic | 0.23 | Best calibration of the four (brier 0.281) and the only one who stress-tested the statistical claims (regime-dependent sign flips, null hypothesis tests) — valuable as a check against overfitting the market price into a 'causal' story, even though its own point estimate still just re-anchors on the same market price. |
- If Atlanta wins the game on 2026-10-12, this forecast (P=0.36) is falsified in the sense that the low-probability outcome occurred; track whether realized outcomes across a larger sample of similar pooled forecasts are well-calibrated (e.g., ATL-style underdogs priced 0.30-0.40 should win 30-40% of the time over a multi-game sample).
- If the market-implied probability for ATL moves materially (e.g., back above 0.45) between 2026-10-11 11:42 UTC and kickoff on 2026-10-12, that would falsify the 'market has already fully priced the injury/news shock' sub-thesis underlying the consensus anchor.
- If a post-game review shows no material injury/news event for either team in the 48 hours before kickoff, that falsifies the d7/d8 injury-shock causal story used to justify trusting the price move.
The seats
Sports Analyst37%
39% NFL home teams win roughly 57% of games historically, but the market-implied price for this specific game (0.385) already reflects BAL being favored on the road, making it a tighter, more relevant base rate than the generic home-field number.
ATL's last two games show +21 margins each (d1 last values), a hot recent streak that a simple 7-game mean or win-rate baseline underweights; if that form is signal rather than noise (sd=22.6 on d1 is very large relative to the mean), ATL's true win probability could be meaningfully above both my estimate and the market's 38.5%, especially combined with home field.
- Most recent, as-of-date (2026-10-11) win-probability readings cluster tightly at 0.385 for ATL, the freshest market signal available before kickoff.
- BAL's 7-game margin series (mean +12.14, last values 18, -7, 3, 6) shows a strong but cooling team, still net positive.
- BAL win rate over last 7 games (mean 0.857) is much higher than ATL's (d3 mean 0.571), supporting BAL as the true favorite.
If the Falcons actually win the 2026-10-12 game (Kalshi KXNFLGAME-26OCT11BALATL-ATL settles YES), this thesis's directional lean toward BAL is falsified; alternatively, if a pre-kickoff inactive-list check shows a key BAL starter ruled out and the market-implied ATL probability moves materially above 0.45 before kickoff, the 'no edge vs. market' claim is falsified.
- d8's most recent cluster of readings (all 0.385, dated 2026-10-11) represents the current market-implied probability for ATL winning this specific game.
- d1 and d2 are ATL's and BAL's respective 7-game scoring-margin histories; d3/d4 are their corresponding win/loss flags over the same window.
- d5/d6 (injuries_out, injuries_questionable) reflect a standard weekly injury-report escalation into game week for one of the two teams; without team attribution I cannot assign directional edge from this series.
- No information after 2026-10-11 11:42 UTC is used; final inactives and weather for the 2026-10-12 kickoff are unknown.
debate skipped: panel unanimous within 0.05
Quantitative Researcher39%
Loading…
Market Positioning Analyst39%
Loading…
Causal Skeptic34%
Loading…
Claims and evidence
The debate
| Sports | Quanti | Market | Causal | |
|---|---|---|---|---|
| Sports | ||||
| Quantitative | ||||
| Market Posit | ||||
| Causal Skept |
Baltimore is the stronger team by recent point differential and win rate, but Atlanta gets home field and enters on a two-game double-digit-margin run; fair value for ATL sits close to, slightly below, the market's current ~38.5% implied price.
Base rate for NFL home teams winning is ~57%, but this specific matchup has team-level and market evidence overriding that generic prior: the market-implied win probability for ATL (d5) has drifted down from a season median of 0.635 to a terminal reading of 0.385, BAL shows a statistically robust positive scoring-margin advantage (s7 CI [3.02,12.17] excludes zero), and a late injury/news signal (d7, d8) spiked in the final 48 hours coincident with that price move. No out-of-sample backtest of an ATL-specific home-field edge was run (data insufficient), so I anchor on the market price as the best available point estimate rather than the generic base rate.
The market-implied probability of an Atlanta win is already converged at ~38.5% (d2, d4 both print 0.385 as of 2026-10-11, the day before kickoff), down from a mid-week reading near 46.5-47% (d3, 2026-10-07) and up from an even earlier stale 0.28-0.29 read (d1, 2026-10-03). This looks like the Ravens-favored line tightening slightly over the week but settling well below the ~57% generic NFL home-win base rate, meaning the market has already priced in Baltimore as the stronger team on the road. Interest/volume proxies (d7, d8) spiked sharply in the final 72 hours (d8 jumping from 1 to 5), consistent with a late news-driven repricing (e.g., injury report) rather than quiet drift, which argues the move is informationally efficient rather than a mispricing an outside analyst can exploit. There is little residual edge beyond the printed 0.385 — any fundamental case for Atlanta has to clear a market that has already moved toward them over the week and is now trading at elevated volume/crowding right before close.
Base rate for a home team winning an NFL game is roughly 0.55. The data presented here (d1-d6, s1-s6) is almost entirely null: every statistical test of a proposed signal (conditional probabilities, OLS regression on is_home, regime splits, hypothesis tests) failed to reject the null at p<0.05, and the one effect that is directionally interesting (home-field beta negative) is both statistically insignificant and regime-dependent (sign flips across periods per s4), which is a textbook sign of confounding or non-stationarity rather than a stable causal mechanism. The only input with real information content is the market-implied probability (d7≈0.42, d8≈0.29), which likely encodes injury/line information unavailable to me, but it is a price — not a validated causal signal — and shows extreme autocorrelation suggesting limited fresh information near game time. I update away from the generic 0.55 home-field base rate toward the market's apparent skepticism about Atlanta, landing around 0.33-0.35, while explicitly flagging that none of the causal claims implied by this analysis survive scrutiny for confounding, regime-dependence, or circularity.
debate skipped: panel unanimous within 0.05
debate skipped: panel unanimous within 0.05
debate skipped: panel unanimous within 0.05
debate skipped: panel unanimous within 0.05
Base rate: generic NFL home win rate ~0.55-0.57 (cited, not re-derived). The panel unanimously updates well below this base rate, to 0.34-0.39, anchored almost entirely on a market-implied probability series that has drifted from 0.635 to 0.385 over the week, reinforced by BAL's statistically positive point-differential (CI excludes zero) and a late injury/news-volume spike. Critically, the four 'confirming' market series (d2, d4, d5, d8) are not independent — lag-1 autocorrelation of 0.997 and cross-correlation of 0.97 show this is largely one slow-moving quote sampled multiple times, so I collapse them into a single line of evidence rather than four. Every fundamental causal/statistical test run by the Causal Skeptic (home-field OLS, regime splits, conditional win-rate comparisons) was null or regime-dependent, meaning the panel has essentially no validated mechanism-level evidence beyond the price itself and BAL's margin advantage.\n\nConsensus: 0.36, CI [0.29, 0.43] — slightly below the deterministic pool (0.37) and below the raw market print (0.385), reflecting (a) treating the duplicated market series as one evidence line rather than several, and (b) crediting the Causal Skeptic's best-in-segment calibration and valid point that no causal signal survived testing, which argues for added caution rather than full trust in the price's precision.\n\nTradeability: NOT tradeable as a standalone edge. The committee's consensus (0.36) and the market's own implied price (0.385) differ by only ~2.5 points, well within the stated CI and almost certainly within typical sportsbook vig/spread. No analyst identified a mispricing the committee can exploit independently of the market itself — the market has already moved from 0.635 to 0.385 ahead of this analysis, i.e., it got there first. If a counterparty is offering ATL win probability meaningfully above 0.40-0.42 (e.g., due to stale pricing), a small fade (short ATL / long BAL) would be consistent with this view; absent that gap, no position is justified given high crowding (0.85) and weak statistical quality (0.45) in the underlying signal set.\n\nTop disagreement: Causal Skeptic (0.34) vs. others (0.37-0.39) on how much trust to place in the market price given that it's a price, not a causal signal, and the duplicated-series problem. Resolved by anchoring on the price as the best available point estimate (it's the freshest, most information-dense input and is consistent with a coherent injury-timing story) while shading down from the raw print to account for the duplication and the lack of any independent corroborating causal evidence.
Assumptions
- holdingd8's most recent cluster of readings (all 0.385, dated 2026-10-11) represents the current market-implied probability for ATL winning this specific game.
- holdingd1 and d2 are ATL's and BAL's respective 7-game scoring-margin histories; d3/d4 are their corresponding win/loss flags over the same window.
- holdingd5/d6 (injuries_out, injuries_questionable) reflect a standard weekly injury-report escalation into game week for one of the two teams; without team attribution I cannot assign directional edge from this series.
- holdingNo information after 2026-10-11 11:42 UTC is used; final inactives and weather for the 2026-10-12 kickoff are unknown.
- holdingd5 represents the time series of the Kalshi/market-implied probability that ATL wins this game (price series, 0-1 scale)
- holdingd1 and d2 represent recent game-level point-differential (margin) series for ATL and BAL respectively, with d2's higher mean/positive CI indicating BAL has outperformed on scoring margin this season
- holdingd3/d4/d6 are binary win/loss indicators for ATL (d3,d6 duplicate) and BAL (d4) over the same game sample
- holdingd7/d8 are daily injury-report or line-movement counts in the days leading into the game, with the sharp rise on 2026-10-10/10-11 reflecting news that moved the market
- holdingNo access to the actual current Vegas spread or starting-QB status beyond what is encoded in d5/d7/d8
- holdingd2 and d4 represent the same or closely related market-implied probability of an Atlanta win, sampled from different windows/sources, both settling at 0.385 as of the as_of date
- holdingd3's decline from ~0.465-0.47 (2026-10-07) to the 0.385 floor by 2026-10-11 reflects a real week-long line move toward Baltimore, not a data artifact
- holdingd7/d8's sharp rise in the final days (d8: 1→5) reflects increased market attention/volume or injury-report activity correlated with the probability settling, not an unrelated metric
- holdingd1's 2026-10-03 stale value (~0.29) is an earlier, less liquid or less informative quote and should be weighted less than the day-of-game reading
- holdingd7 and d8 are market-implied probability series for the ATL-win contract or a closely related contract, not independently verified as causal inputs
- holdingd1-d6 represent team-level historical game indicators/point differentials for ATL and BAL in some rolling window, but exact definitions were not confirmed from the data handles alone
- holdingNo injury, QB-status, or weather data were supplied, so any 'home field advantage' claim cannot be causally isolated from team quality, rest, or travel confounders
- holdingSample sizes (n=22-49) are too small to detect a true home-field effect of the typical NFL magnitude (~2-3 points) with any power
Simulated trade
The portfolio manager proposed no paper trade. Two independent blockers. (1) Instrument-universe mismatch: the only tradeable instruments in this book (HENRY_HUB, UNG, XLE, VLO, MPC, PSX, CORN, BTC, ETH, WTI) are energy/commodity/crypto tickers with no causal or statistical linkage to an NFL game outcome — there is no sports-outcome contract, correlated proxy, or sponsorship/ownership-linked equity in the catalog that would let ATL-vs-BAL exposure be expressed without fabricating a relationship. (2) Even if a sports-outcome contract existed, the synthesis itself found no exploitable edge: committee consensus (0.36) and the market-implied price (0.385) sit ~2.5pts apart, inside the stated CI [0.29,0.43] and almost certainly inside typical vig, with crowding=0.85 and statistical_quality=0.45 on a signal set that collapses to one duplicated market-price series once autocorrelation (0.997) and cross-correlation (0.97) are accounted for. No analyst produced an independent causal or mechanism-level signal (home-field OLS and regime splits were null) that would justify a position against the market's own price, which already moved from 0.635 to 0.385 ahead of this analysis — the market got there first. Recommendation: no trade. If a counterparty elsewhere is quoting ATL win probability materially above ~0.40-0.42 on a venue that actually lists this market, that stale-quote gap — not anything in this instrument catalog — would be the only legitimate edge, and it is not accessible here.
Forecasts
| Seat | Stage | P | Base | Resolves | Outcome | Brier |
|---|---|---|---|---|---|---|
| Committee | final | 37% | — | 2026-10-12 | No | 0.138 |
| Sports Analyst | prior | 33% | 39% | 2026-10-12 | No | 0.109 |
| Sports Analyst | independent | 37% | 39% | 2026-10-12 | No | 0.137 |
| Sports Analyst | revised | 37% | 39% | 2026-10-12 | No | 0.137 |
| Quantitative Researcher | prior | 42% | 57% | 2026-10-12 | No | 0.176 |
| Quantitative Researcher | independent | 39% | 57% | 2026-10-12 | No | 0.148 |
| Quantitative Researcher | revised | 39% | 57% | 2026-10-12 | No | 0.148 |
| Market Positioning Analyst | prior | 42% | 57% | 2026-10-12 | No | 0.176 |
| Market Positioning Analyst | independent | 39% | 57% | 2026-10-12 | No | 0.152 |
| Market Positioning Analyst | revised | 39% | 57% | 2026-10-12 | No | 0.152 |
| Causal Skeptic | prior | 30% | 55% | 2026-10-12 | No | 0.090 |
| Causal Skeptic | independent | 34% | 55% | 2026-10-12 | No | 0.116 |
| Causal Skeptic | revised | 34% | 55% | 2026-10-12 | No | 0.116 |